Correlation Between Black Diamond and Abeona Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Black Diamond and Abeona Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Black Diamond and Abeona Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Black Diamond Therapeutics and Abeona Therapeutics, you can compare the effects of market volatilities on Black Diamond and Abeona Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Black Diamond with a short position of Abeona Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Black Diamond and Abeona Therapeutics.

Diversification Opportunities for Black Diamond and Abeona Therapeutics

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Black and Abeona is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Black Diamond Therapeutics and Abeona Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abeona Therapeutics and Black Diamond is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Black Diamond Therapeutics are associated (or correlated) with Abeona Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abeona Therapeutics has no effect on the direction of Black Diamond i.e., Black Diamond and Abeona Therapeutics go up and down completely randomly.

Pair Corralation between Black Diamond and Abeona Therapeutics

Given the investment horizon of 90 days Black Diamond Therapeutics is expected to generate 2.19 times more return on investment than Abeona Therapeutics. However, Black Diamond is 2.19 times more volatile than Abeona Therapeutics. It trades about 0.18 of its potential returns per unit of risk. Abeona Therapeutics is currently generating about -0.11 per unit of risk. If you would invest  214.00  in Black Diamond Therapeutics on November 3, 2024 and sell it today you would earn a total of  48.00  from holding Black Diamond Therapeutics or generate 22.43% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Black Diamond Therapeutics  vs.  Abeona Therapeutics

 Performance 
       Timeline  
Black Diamond Therap 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Black Diamond Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Abeona Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Abeona Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Black Diamond and Abeona Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Black Diamond and Abeona Therapeutics

The main advantage of trading using opposite Black Diamond and Abeona Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Black Diamond position performs unexpectedly, Abeona Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abeona Therapeutics will offset losses from the drop in Abeona Therapeutics' long position.
The idea behind Black Diamond Therapeutics and Abeona Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities